BioPower Operations
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioPower Operations generated cash of $306,111, which is more than the previous year. Cash used in financing activities reached the amount of -$401,259 last year. Net change in cash is therefore -$95,148.
Cash Flow
| 2012 | -242.19K | 52.56K | 200.47K |
|---|---|---|---|
| 2013 | -236.57K | -15.61K | 344.40K |
| 2014 | -332.5K | -4.75K | 243.2K |
| 2015 | -286.44K | -9.04K | 281.65K |
| 2019 | 129.74K | 0 | 0 |
| 2020 | 129.74K | 0 | 0 |
| 2021 | -204.02K | 0 | 300K |
| 2022 | 306.11K | 0 | -401.25K |
BOPO Cash Flow Statement (2012 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 95.97K | 0 | 1.28K | 0 | 15.11K | 109.17K | 16.95K | 6.11K |
Operating activities | ||||||||
Net income | -792.53K | -441.32K | -129.74K | -129.74K | -2.21M | -2.09M | -1.34M | -1.27M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 9.21K | 12.34K | 5.55K | 10.55K |
Stock-based compensation expense | 0 | 2.5K | 0 | 0 | 75.83K | 343.25K | 436.22K | 0 |
| Deferred income tax benefit | 0 | 2.5K | 0 | 0 | 75.83K | 343.25K | 436.22K | 0 |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | -331 | 0 | 0 | 0 | 0 | 27.84K | -27.84K | 0 |
Inventories | -12.89K | 0 | 0 | 0 | 0 | 2.49M | 420.88K | 0 |
Accounts payable | 12.87K | 195.26K | 44.99K | 0 | 21.45K | -71.92K | 35.32K | 0 |
Cash generated by operating activities | 306.11K | -204.02K | 129.74K | 129.74K | -286.44K | -332.5K | -236.57K | -242.19K |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1 | 0 | 0 | 0 | -9.04K | -4.75K | -15.61K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | -9.04K | -4.75K | -15.61K | 52.56K |
Financing activities | ||||||||
Common Stock Issued | 374.99K | 2.5K | 0 | 0 | 75K | 209.62K | 12.9K | 50K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -776.25K | 0 | 0 | 0 | 14.15K | -243.2K | 0 | -1K |
Cash used in financing activities | -401.25K | 300K | 0 | 0 | 281.65K | 243.2K | 344.40K | 200.47K |
Net Change In Cash | -95.14K | 95.97K | 129.74K | 129.74K | -13.83K | -94.05K | 92.21K | 10.84K |
Cash at end of period | 825 | 95.97K | 131.02K | 129.74K | 1.28K | 15.11K | 109.17K | 16.95K |
| Data source | Data source | Data source | Data source | Data source | Data source |